|Articles|October 12, 2020
Analysis of Camelid Single-Domain Antibodies Using Agilent AdvanceBio SEC 120 Å 1.9 μm and AdvanceBio HIC Columns
Author(s)Agilent Technologies
How to use of size exclusion chromatography (SEC) and hydrophobic interaction chromatography (HIC) for the analysis of camelid single-domain antibodies (nanobodies).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Why Radiopharmaceuticals Are Ideal for Treating Cancer
5
